Ingredient or product comparison
GHK-Cu Studied Skin Aging: Comparison of Delivery Methods
Topical cream (1–3%) Limited to epidermis and upper dermis; <5% penetration to deep dermis 4–8 weeks for visible improvement; 12 weeks for maximal structural change Effects plateau after 12–16 weeks with continued use Requires twice-daily application; efficacy
This source-based comparison does not add ratings or recommend a winner.
- Topical cream (1–3%)
- Limited to epidermis and upper dermis; <5% penetration to deep dermis
- 4–8 weeks for visible improvement; 12 weeks for maximal structural change
- Effects plateau after 12–16 weeks with continued use
- Requires twice-daily application; efficacy depends on formulation pH (optimal 5.0–6.5) and copper stability
- Best for photoaging and surface-level fine lines; safe for long-term use with minimal irritation risk
- Microneedling + topical
- Enhanced dermal penetration (up to 10× vs topical alone)
- 2–6 weeks for initial improvement; synergistic with collagen induction from needling
- Single session effects visible 4–8 weeks; maintenance every 4–6 months
- Requires sterile technique and post-procedure downtime (3–5 days redness); contraindicated in active acne or rosacea
- Superior for deeper wrinkles and dermal atrophy; combines mechanical and biochemical remodeling
- Subcutaneous injection (research context)
- Direct delivery to target tissue; avoids first-pass degradation
- 1–3 weeks for localized tissue response
- Depends on injection frequency (weekly protocols common in trials)
- Requires medical oversight; risk of injection-site inflammation; not FDA-approved for cosmetic use
- Produces most robust structural changes in controlled studies; not practical for consumer use
- Oral supplementation
- Poor bioavailability; extensive first-pass metabolism; GHK-Cu degrades in gastric acid
- Minimal to no measurable effect on skin markers
- Not established
- No evidence of systemic absorption at cosmetically relevant concentrations
- Not supported by current evidence. Topical or injectable routes required for dermatological effects